| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.29B | 6.62B | 6.74B | 4.87B | 6.47B | 2.30B |
| Gross Profit | 892.00M | 730.64M | 514.88M | 824.34M | 1.10B | 485.63M |
| EBITDA | 332.44M | 321.22M | 304.79M | 351.26M | 374.58M | 148.78M |
| Net Income | 23.90M | 31.33M | 61.27M | 175.69M | 197.89M | 62.00M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 3.54B | 3.64B | 2.70B | 2.28B | 1.38B |
| Cash, Cash Equivalents and Short-Term Investments | 21.14M | 21.14M | 11.52M | 8.04M | 4.02M | 5.32M |
| Total Debt | 0.00 | 2.39B | 2.57B | 1.57B | 1.39B | 766.61M |
| Total Liabilities | -825.77M | 2.72B | 2.84B | 1.96B | 1.71B | 1.00B |
| Stockholders Equity | 825.77M | 825.77M | 797.68M | 741.80M | 572.40M | 380.17M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 187.61M | -840.64M | -85.92M | -547.00M | -301.92M |
| Operating Cash Flow | 0.00 | 450.40M | -119.04M | -50.15M | -347.82M | -237.47M |
| Investing Cash Flow | 0.00 | -262.64M | -719.09M | -33.88M | -195.08M | -52.88M |
| Financing Cash Flow | 0.00 | -187.22M | 838.08M | 83.94M | 541.57M | 290.48M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
55 Neutral | ₹1.37B | 108.07 | ― | 0.36% | -13.03% | -81.40% | |
55 Neutral | ₹1.08B | 19.64 | ― | ― | 4.60% | 226.64% | |
55 Neutral | ₹1.13B | 19.17 | ― | ― | 8.45% | ― | |
52 Neutral | ₹748.59M | 26.43 | ― | ― | ― | ― | |
46 Neutral | ₹976.05M | -6.42 | ― | ― | -30.97% | 80.99% |
Salona Cotspin Limited has disclosed that it received an order from the Registrar of Companies, Coimbatore, for a procedural lapse under the Companies Act, 2013 related to a two-day delay in filing E-form MGT-15 for the financial year 2021-22. The company clarified that the order does not impose any monetary penalty on either the company or its officers and that the action has no significant impact on its financials, operations, or other business activities, indicating that the issue is a minor compliance matter rather than a substantive regulatory setback.